METiS Pharmaceuticals is based in Beijing, China. It has raised $86M in total funding. Latest round: Series A.
METiS Pharmaceuticals is based in Beijing, China. METiS Pharmaceuticals has raised $86M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for METiS Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include PICC PE, China Life, Sequoia Capital China, Lightspeed, 5Y Capital. 5 distinct backers are named across the disclosed rounds.
METiS Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Beijing below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide